[ad_1] The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims of six states that…
Tag: Eye Conditions
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
[ad_1] The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. [ad_2] Source link
Screens, Lack of Sun Are Causing an Epidemic of Myopia
[ad_1] Nearsightedness is on the rise worldwide, but there are ways to help children preserve their vision. [ad_2] Source link
First Test for Amgen: Fix Horizon’s Growth Problem
[ad_1] Markets Heard on the Street Sales of Horizon’s thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with [ad_2] Source link